Genomic Differences and Distinct <i>TP53</i> Mutation Site‐Linked Chemosensitivity in Early‐ and Late‐Onset Gastric Cancer
Genomic differences, particularly in TP53 mutation sites, between early- and late-onset GC support the need for age-specific treatment strategies.
Authors
- Shinichi Toyooka (ORCID: https://orcid.org/0000-0002-7588-6745)
- Kensuke Hirosuna (ORCID: https://orcid.org/0000-0002-9263-4929)
- Yoshiyasu Kono (ORCID: https://orcid.org/0000-0002-4717-5196)
- Toshiki Ozato (ORCID: https://orcid.org/0009-0003-9738-8768)
- Shuta Tomida
- Motoyuki Otsuka (ORCID: https://orcid.org/0000-0003-2869-2881)
- Daisuke Ennishi (ORCID: https://orcid.org/0000-0003-4788-2103)
- Akira Hirasawa (ORCID: https://orcid.org/0000-0003-4124-5488)
- Hideki Yamamoto (ORCID: https://orcid.org/0000-0003-4919-3483)
- Tomohiro Kamio
Institutions
- Okayama University (JP)
- Okayama University Hospital (JP)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1002/cam4.70793
- Citations
- 3
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- Mitsubishi Foundation
- Foundation for Promotion of Cancer Research
- Japan Society for the Promotion of Science